Webinar: Optimizing Treatment Selection: Exploring A New Technology To Personalize Therapy Beyond Any Standard Approach

REGISTER: https://bit.ly/3V5JSjm

The Appendix Cancer PMP Research Foundation (ACPMP) is working with Travera, a company whose mission is to bring hope to cancer patients who are running out of therapeutic options. Through its collaboration with ACPMP, Travera is offering its 2-day Rapid Therapy Selection™ test to patients with appendiceal and peritoneal cancers free of charge to help in their efforts to establish more treatment options and outcomes data.

Travera is doing work in appendiceal cancer as part of its larger focus on other gastrointestinal cancers and gynecologic cancers. They are assisting oncologists in selecting treatments for their patients using a revolutionary cancer therapy selection test that predicts which cancer drugs are most likely to be effective for each cancer patient, a potentially valuable tool for patients with rare or advanced diseases. This novel technology invented at MIT has overcome the problems that have prevented the many previous generations of therapy selection tests from being effective in clinical practice.

We invite patients, families, and healthcare providers to join us to hear more about this offering in a webinar on June 13th at 7pm Eastern. If you’d like to learn more about testing and potentially initiate the testing process prior to the webinar, you can follow this link to learn more: https://www.travera.com/contact

Here is a brief description of the test to get you started: https://youtu.be/REzqlDYPeIw.